Clinical trials
Observational Non-Muscle Invasive Bladder Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 3 |
| 2021 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
| Completed | 5 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endo USA Inc., a Keenova Therapeutics Company | 2 |
| Photocure | 2 |
| University of Washington | 2 |
| Arquer Diagnostics Ltd | 1 |
| Convergent Genomics, Inc. | 1 |
| Ferring Pharmaceuticals | 1 |
| Genomic Health®, Inc. | 1 |
| ImmunityBio, Inc. | 1 |
| Janssen Research & Development, LLC | 1 |
| Johns Hopkins University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 18 |
| Urinary Bladder Neoplasms | 9 |
| Carcinoma, Transitional Cell | 1 |
| Hematuria | 1 |
| Neoplasms | 1 |
| Neoplasms by Site | 1 |
| Recurrence | 1 |
| Urinary Bladder Diseases | 1 |
| Urogenital Neoplasms | 1 |
| Urologic Diseases | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.